AR-A000002

AR-A000002
IUPAC ime
(R)-N-[5-metil-8-(4-metilpiperazin-1-il)-1,2,3,4-tetrahidro-2-naftil]-4-morfolinobenzamid
Identifikatori
ATC kodnone
PubChemCID 9846516
ChemSpider8022230
Hemijski podaci
FormulaC27H36N4O2
Molarna masa448,599 g/mol
  • C5COCCN5c(cc4)ccc4C(=O)NC2CCc1c(C2)c(ccc1C)N3CCN(C)CC3
  • InChI=1S/C27H36N4O2/c1-20-3-10-26(31-13-11-29(2)12-14-31)25-19-22(6-9-24(20)25)28-27(32)21-4-7-23(8-5-21)30-15-17-33-18-16-30/h3-5,7-8,10,22H,6,9,11-19H2,1-2H3,(H,28,32)/t22-/m1/s1 ДаY
  • Key:IHDRUIHIJWCTIY-JOCHJYFZSA-N ДаY

AR-A000002 je lek, koji jedno od prvih jedinjenja razvijenih da deluje kao selektivni antagonist za serotoninski receptor 5-HT1B,[1] sa približno 10x većom selektivnošću za 5-HT1B u odnosu na srodni 5-HT1D receptor.[2] Bilo je pokazano da proizvodi održivo povećanje nivoa serotonina u mozgu, i da ima anksiolitsko dejstvo u životinjskim studijama.[3][4]

Reference

[уреди | уреди извор]
  1. ^ Hudzik TJ, Yanek M, Porrey T, Evenden J, Paronis C, Mastrangelo M, Ryan C, Ross S, Stenfors C. Behavioral pharmacology of AR-A000002, a novel, selective 5-hydroxytryptamine(1B) antagonist. Journal of Pharmacology and Experimental Therapeutics. 2003 Mar;304(3):1072-84. PMID 12604684
  2. ^ Ahlgren C, Eriksson A, Tellefors P, Ross SB, Stenfors C, Malmberg A. In vitro characterization of AR-A000002, a novel 5-hydroxytryptamine(1B) autoreceptor antagonist. European Journal of Pharmacology. 2004 Sep 19;499(1-2):67-75. PMID 15363952
  3. ^ Stenfors C, Ahlgren C, Yu H, Wedén M, Larsson LG, Ross SB. Effects of long-term administration of the 5-hydroxytryptamine1B receptor antagonist AR-A000002 to guinea pigs. Psychopharmacology (Berlin). 2004 Mar;172(3):333-40. PMID 14652708
  4. ^ Stenfors C, Hallerbäck T, Larsson LG, Wallsten C, Ross SB. Pharmacology of a novel selective 5-hydroxytryptamine1B receptor antagonist, AR-A000002. Naunyn Schmiedebergs Archives of Pharmacology. 2004 Mar;369(3):330-7. PMID 14758468